New questions about lung cancer in ‘never-smokers’ As the number of people who smoke has gone down over the decades, those who never smoked have begun to make up a greater proportion of lung cancer ...
Stocks were poised for a higher open Thursday, a day after major equities indexes ticked lower, with the Dow Jones Industrial Average snapping a three-session winning streak during which it set ...
Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" o ...
Royalty Pharma plc (NASDAQ:RPRX) Q4 2025 Earnings Call Transcript February 11, 2026 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.47, expectations were $1.33. Operator: Ladies and ...
PiNACLE - H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator’s choice of ...
Oral presentation to highlight updated Phase 1 monotherapy safety and efficacy data for TOS-358, a covalent PI3Ka inhibitor ...
New sublingual delivery system designed to provide more rapid relief from nausea caused by cancer medicinesOndansetron, currently sold under the brand name Zofran, was the 53rd most commonly prescribe ...
29mon MSN
AI drug discovery company Amply Discovery secures strategic investment from South Korea biomed giant
Partnership announced as former Queen's University spin-out appoints Dr Oliver Rausch as chief scientific officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results